{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:16:55Z","timestamp":1780373815056,"version":"3.54.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P26251"],"award-info":[{"award-number":["P26251"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.peptides.2023.171077","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T04:20:53Z","timestamp":1691641253000},"page":"171077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The angiogenic neuropeptide catestatin exerts beneficial effects on human coronary vascular cells and cardiomyocytes"],"prefix":"10.1016","volume":"168","author":[{"given":"Daniela","family":"Lener","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Noflatscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Kirchmair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Holfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Gollmann-Tepek\u00f6yl\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Kirchmair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3609-9730","authenticated-orcid":false,"given":"Markus","family":"Theurl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10159","key":"10.1016\/j.peptides.2023.171077_bib1","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"Collaborators","year":"2018","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.peptides.2023.171077_bib2","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/j.jacc.2019.10.009","article-title":"The global burden of cardiovascular diseases and risk factors: 2020 and beyond","volume":"74","author":"Mensah","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"25","key":"10.1016\/j.peptides.2023.171077_bib3","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","article-title":"The global burden of cardiovascular diseases and risk: a compass for future health","volume":"80","author":"Vaduganathan","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.peptides.2023.171077_bib4","first-page":"886","article-title":"Patients with coronary artery disease not amenable to traditional revascularization: prevalence and 3-year mortality","volume":"75","author":"Williams","year":"2010","journal-title":"Catheter Cardiovasc. Interv."},{"issue":"5","key":"10.1016\/j.peptides.2023.171077_bib5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/euhj.2001.2706","article-title":"The problem of chronic refractory angina; report from the ESC Joint Study Group on the Treatment of Refractory Angina","volume":"23","author":"Mannheimer","year":"2002","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.peptides.2023.171077_bib6","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ejhf.822","article-title":"Do patients have worse outcomes in heart failure than in cancer? A primary care-based cohort study with 10-year follow-up in Scotland","volume":"19","author":"Mamas","year":"2017","journal-title":"Eur. J. Heart Fail"},{"issue":"21","key":"10.1016\/j.peptides.2023.171077_bib7","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1161\/CIRCULATIONAHA.111.076950","article-title":"The angiogenic factor secretoneurin induces coronary angiogenesis in a model of myocardial infarction by stimulation of vascular endothelial growth factor signaling in endothelial cells","volume":"126","author":"Albrecht-Schgoer","year":"2012","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.peptides.2023.171077_bib8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2362.2010.02282.x","article-title":"The human coronary collateral circulation","volume":"40","author":"Seiler","year":"2010","journal-title":"Eur. J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.peptides.2023.171077_bib9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/01.CIR.0000112574.07422.C1","article-title":"The neuropeptide secretoneurin acts as a direct angiogenic cytokine in vitro and in vivo","volume":"109","author":"Kirchmair","year":"2004","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.peptides.2023.171077_bib10","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/CIRCRESAHA.110.219493","article-title":"The neuropeptide catestatin acts as a novel angiogenic cytokine via a basic fibroblast growth factor-dependent mechanism","volume":"107","author":"Theurl","year":"2010","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.peptides.2023.171077_bib11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/cvr\/cvu237","article-title":"Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E(-)\/(-) mice without influencing systemic atherosclerosis","volume":"105","author":"Theurl","year":"2015","journal-title":"Cardiovasc. Res."},{"issue":"Suppl 1","key":"10.1016\/j.peptides.2023.171077_bib12","first-page":"II230","article-title":"Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure","volume":"108","author":"Jayasankar","year":"2003","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.peptides.2023.171077_bib13","doi-asserted-by":"crossref","first-page":"H278","DOI":"10.1152\/ajpheart.00471.2017","article-title":"VEGF nanoparticles repair the heart after myocardial infarction","volume":"314","author":"Oduk","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"10","key":"10.1016\/j.peptides.2023.171077_bib14","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1161\/CIRCRESAHA.109.199513","article-title":"Gene therapy with the angiogenic cytokine secretoneurin induces therapeutic angiogenesis by a nitric oxide-dependent mechanism","volume":"105","author":"Schgoer","year":"2009","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.peptides.2023.171077_bib15","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2353\/ajpath.2007.070003","article-title":"Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular function","volume":"171","author":"Virag","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"11","key":"10.1016\/j.peptides.2023.171077_bib16","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/nm1313","article-title":"Sonic hedgehog myocardial gene therapy: tissue repair through transient reconstitution of embryonic signaling","volume":"11","author":"Kusano","year":"2005","journal-title":"Nat. Med."},{"issue":"5787","key":"10.1016\/j.peptides.2023.171077_bib17","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1126\/science.1124704","article-title":"Netrins promote developmental and therapeutic angiogenesis","volume":"313","author":"Wilson","year":"2006","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.peptides.2023.171077_bib18","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1161\/01.CIR.97.12.1114","article-title":"Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia","volume":"97","author":"Baumgartner","year":"1998","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.peptides.2023.171077_bib19","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/hc1102.105595","article-title":"Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris","volume":"105","author":"Grines","year":"2002","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.peptides.2023.171077_bib20","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/01.CIR.0000015982.70785.B7","article-title":"Phase 1\/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia","volume":"105","author":"Losordo","year":"2002","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.peptides.2023.171077_bib21","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1161\/01.CIR.98.25.2800","article-title":"Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia","volume":"98","author":"Losordo","year":"1998","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.peptides.2023.171077_bib22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1161\/01.CIR.100.5.468","article-title":"Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease","volume":"100","author":"Rosengart","year":"1999","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.peptides.2023.171077_bib23","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1172\/JCI16929","article-title":"Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles","volume":"111","author":"Lee","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.peptides.2023.171077_bib24","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMra021405","article-title":"The chromogranin-secretogranin family","volume":"348","author":"Taupenot","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.peptides.2023.171077_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0167-0115(03)00069-7","article-title":"Catestatin (CgA344-364) stimulates rat mast cell release of histamine in a manner comparable to mastoparan and other cationic charged neuropeptides","volume":"114","author":"Kruger","year":"2003","journal-title":"Regul. Pept."},{"key":"10.1016\/j.peptides.2023.171077_bib26","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1749-6632.2002.tb04493.x","article-title":"Catestatin (chromogranin A344-358) stimulates release of histamine from rat pleural and peritoneal mast cells","volume":"971","author":"Kruuger","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.peptides.2023.171077_bib27","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1172\/JCI119686","article-title":"Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist","volume":"100","author":"Mahata","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.peptides.2023.171077_bib28","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/sj.jid.5701225","article-title":"The neuroendocrine peptide catestatin is a cutaneous antimicrobial and induced in the skin after injury","volume":"128","author":"Radek","year":"2008","journal-title":"J. Invest Dermatol."},{"issue":"3","key":"10.1016\/j.peptides.2023.171077_bib29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00441-010-1059-4","article-title":"Chromogranin\/secretogranin proteins in murine heart: myocardial production of chromogranin A fragment catestatin (Chga(364-384))","volume":"342","author":"Biswas","year":"2010","journal-title":"Cell Tissue Res."},{"issue":"24","key":"10.1016\/j.peptides.2023.171077_bib30","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.2174\/092986712802429966","article-title":"Cardioprotection against ischemia\/reperfusion injury and chromogranin A-derived peptides","volume":"19","author":"Penna","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"10.1016\/j.peptides.2023.171077_bib31","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/cvr\/cvr129","article-title":"A novel catestatin-induced antiadrenergic mechanism triggered by the endothelial PI3K-eNOS pathway in the myocardium","volume":"91","author":"Bassino","year":"2011","journal-title":"Cardiovasc. Res."},{"issue":"1\u20133","key":"10.1016\/j.peptides.2023.171077_bib32","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejphar.2008.09.016","article-title":"Monocyte migration: a novel effect and signaling pathways of catestatin","volume":"598","author":"Egger","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.peptides.2023.171077_bib33","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1096\/fj.09-143180","article-title":"Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction","volume":"24","author":"Zentilin","year":"2010","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.peptides.2023.171077_bib34","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1161\/01.RES.0000154595.87608.db","article-title":"Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation","volume":"96","author":"Millette","year":"2005","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.peptides.2023.171077_bib35","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1152\/jappl.2001.91.4.1819","article-title":"PI3-kinase\/Akt modulates vascular smooth muscle tone via cAMP signaling pathways (1985)","volume":"91","author":"Komalavilas","year":"2001","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.peptides.2023.171077_bib36","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.biopha.2018.05.113","article-title":"Vascular smooth muscle cells activate PI3K\/Akt pathway to attenuate myocardial ischemia\/reperfusion-induced apoptosis and autophagy by secreting bFGF","volume":"107","author":"Ye","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.peptides.2023.171077_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2019.170200","article-title":"Catestatin in defense of oxidative-stress-induced apoptosis: a novel mechanism by activating the beta2 adrenergic receptor and PKB\/Akt pathway in ischemic-reperfused myocardium","volume":"123","author":"Chu","year":"2020","journal-title":"Peptides"},{"issue":"3","key":"10.1016\/j.peptides.2023.171077_bib38","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1160\/TH09-08-0520","article-title":"Effect of intramyocardial delivery of autologous bone marrow mononuclear stem cells on the regional myocardial perfusion. NOGA-guided subanalysis of the MYSTAR prospective randomised study","volume":"103","author":"Charwat","year":"2010","journal-title":"Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.peptides.2023.171077_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022550","article-title":"Improvement of cardiac function in mouse myocardial infarction after transplantation of epigenetically-modified bone marrow progenitor cells","volume":"6","author":"Rajasingh","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.peptides.2023.171077_bib40","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.scr.2011.01.001","article-title":"Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction","volume":"6","author":"Timmers","year":"2011","journal-title":"Stem Cell Res."},{"issue":"8","key":"10.1016\/j.peptides.2023.171077_bib41","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s10571-010-9598-5","article-title":"Catestatin improves post-ischemic left ventricular function and decreases ischemia\/reperfusion injury in heart","volume":"30","author":"Penna","year":"2010","journal-title":"Cell Mol. Neurobiol."},{"issue":"8","key":"10.1016\/j.peptides.2023.171077_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102536","article-title":"Catestatin increases the expression of anti-apoptotic and pro-angiogenetic factors in the post-ischemic hypertrophied heart of SHR","volume":"9","author":"Penna","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.peptides.2023.171077_bib43","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00424-013-1217-0","article-title":"Catestatin reduces myocardial ischaemia\/reperfusion injury: involvement of PI3K\/Akt, PKCs, mitochondrial KATP channels and ROS signalling","volume":"465","author":"Perrelli","year":"2013","journal-title":"Pflug. Arch."},{"issue":"1 Pt 2","key":"10.1016\/j.peptides.2023.171077_bib44","first-page":"H142","article-title":"Mitogen-activated protein kinase and proliferation of human vascular smooth muscle cells","volume":"270","author":"Mii","year":"1996","journal-title":"Am. J. Physiol."},{"issue":"11","key":"10.1016\/j.peptides.2023.171077_bib45","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1093\/cvr\/cvab046","article-title":"Vascular smooth muscle cells in atherosclerosis: time for a re-assessment","volume":"117","author":"Grootaert","year":"2021","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.peptides.2023.171077_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037401","article-title":"Secretogranin II; a protein increased in the myocardium and circulation in heart failure with cardioprotective properties","volume":"7","author":"Rosjo","year":"2012","journal-title":"PLoS One"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978123001407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978123001407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:35:23Z","timestamp":1759311323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978123001407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":46,"alternative-id":["S0196978123001407"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2023.171077","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The angiogenic neuropeptide catestatin exerts beneficial effects on human coronary vascular cells and cardiomyocytes","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2023.171077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"171077"}}